Products with Anti-inflammatory bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN1191 | Pedunculoside |
| Pedunculoside shows significant hypocholesterolemic and anti-inflammatory activities, it shows potential nitric oxide inhibitory activities with the IC50 value ranging from 14.92 uM to 52.23 uM. | |
| BCN1192 | Zingerone |
| Zingerone has anti-mutagenic, anti-carcinogenic, anti-obesity,anti-oxidative and anti-inflammatory activities. Zingerone can be recommended as a supplement to shrimp feed to increase growth, immunity, and disease resistance against the pathogen, V.alginolyticus , use of zingerone as appetizer and immunostimulant in shrimp is promising. It could as potential phytotherapeutic agent which in future can be employed to formulate preventive strategies against biofilm associated infections caused by P.aeruginosa. | |
| BCN1193 | alpha-Cyperone |
| Alpha-cyperone is associated with the down-regulation of COX-2,IL-6,Nck-2,Cdc42 and Rac1, resulting in reduction of inflammation. which would be highly beneficial for treatment of inflammatory diseases such as AD. Alpha-cyperone is a promising inhibitor of Hla production by S. aureus and protects lung cells from this bacterium, it also shows inhibitory effects on adherence and invasion of avian pathogenic Escherichia coli O78 to chicken type II pneumocytes. | |
| BCN1194 | Sanggenone D |
| 1. Sanggenones D, B, O,G show an antifungal activity with IC50 values between 10 and 123 microM. 2. Sanggenones(sanggenones C, D) represent a new scaffold of positive GABAA receptor modulators. 3. Sanggenones D, C and kazinol B inhibit COX-2 activity (ic 50 = 73-100 μM). 4. Sanggenone D has anti-inflammatory activity, it can inhibit NO production from lipopolysaccharide (LPS)-induced RAW 264.7 cells at > 10 uM; inhibition of nitric oxide production was mediated by suppression of iNOS enzyme induction but not by direct inhibition of iNOS enzyme activity. | |
| BCN1198 | Schisandrin C |
| Schizandrin C isolated from Schisandra chinensis could be used as a natural anti-neuroinflammatory agent, inducing phase II detoxifying/antioxidant enzymes via cAMP/PKA/CREB and Nrf-2 signaling. | |
